TEL AVIV, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative ...
ORLANDO -- Non-injection routes of epinephrine delivery are gaining proponents for rapid response to immunotherapy anaphylaxis in the allergists' office. "I was pretty shocked the first time I used it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback